2022

Targets and challenges of Pharma Supply Chain Manufacturers

by cyb2025

PAOLO PAISSONI
R&D and Business Development Director
Procos S.p.A.
Member of Chimica Oggi – Chemistry Today Scientific Advisory Board

After almost two years of COVID-19 pandemic, we are still in a condition where we are not able to go everywhere, seeing each other to discuss ideas and projects, mainly managing videocalls, webinars, remote meetings and conferences. Something is moving on, though not as in the past.

 

However, challenges for pharmaceutical space have not changed at all, even enforced by the pandemic. Vaccines have involved several companies, innovators and manufacturers, the efforts have been and are great, supporting properly the needs. Actually, it is still a work in progress.

 

ABOUT THE AUTHOR

With more than 30 years of experience focused on research and development in the pharmaceutical industry, Dr. Paolo Paissoni, is passionate about innovation and cooperation in drug substance development, as it sets the pathway for successful clinicals and commercialization. Paolo has held positions at esteemed companies including Farmitalia Carlo Erba, then Antibioticos S.p.A., becoming Head of R&D for Extraction and Chemistry for 16 years, then joining Procos S.p.A. in 2006, as the Head of R&D and Business Development. Moreover, he is currently serving as an active Board Member of CBC-Procos S.p.A since 2009.

Login